Medical Device Regulation in United Kingdom
Post-Brexit, the UK has its own regulatory framework overseen by the MHRA. CE marking remains accepted for the Great Britain market during an extended transition period. Northern Ireland follows EU MDR. Reformed UK MDR regulations are under development and expected to broadly mirror EU MDR.
Recent Regulatory Updates
Showing the latest 3 updates. Sign up to see more
Enhanced ILAP TDP streamlines development pathway
No substantive changes, only website updates.
UK reviews SoHO regulations, seeks stakeholder input
Sources Tracked by Qalico
Qalico continuously monitors 15 references across guidelines, regulations, and standards for United Kingdom.
Regulations
Guidelines
Device Classification
Aligned with the former EU MDD classification rules. Class I: lowest risk (self-declaration). Class IIa/IIb: medium risk, Approved Body required. Class III: highest risk, enhanced scrutiny. New UK MDR reforms expected to align fully with EU MDR 2017/745 classification rules.
Official classification guidance →Official Guidance Documents
Standards & Key Principles
Applicable Standards
Key Principles
- UKCA marking for GB; CE mark accepted until June 2030 transition
- Northern Ireland follows EU MDR pathways
- UK Approved Bodies (equivalent of EU Notified Bodies)
- UK Responsible Person required for foreign manufacturers
- MHRA Yellow Card vigilance reporting system
- MHRA registration mandatory before market placement
Pre-Market Requirements
All devices placed on the UK market must be registered with MHRA. Foreign manufacturers without UK establishment must appoint a UK Responsible Person.
Class IIa, IIb, and III require conformity assessment by a UK Approved Body. CE marking from EU Notified Bodies accepted during transition.
Non-UK manufacturers must appoint a UKRP established in Great Britain to represent them with MHRA.
Post-Market Requirements
Serious incidents reported to MHRA via Yellow Card: 2 days for imminent danger, 10 days for deaths/serious injuries, 30 days for others.
Requirements broadly aligned with former EU MDD and evolving toward MDR-equivalent obligations.
Manufacturers must notify MHRA and issue Field Safety Notices for any FSCA affecting the UK market.
International Recognition & Reliance
CE marking accepted for the Great Britain market until June 2030 for most device classes.